Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
28slipping
Latest NAV
₹52.0027
as of 07 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
28/100slipping
Rank #217 of 322 · top 72%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
4.33%
3M
10.39%
6M
22.46%
1Y
17.77%
3Y CAGR
22.19%
5Y CAGR
—
Since incep.
22.22%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap46.3%
Mid cap26.7%
Small cap27.1%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Apr 2026.
Sun Pharmaceutical Industries Limited
equity
13.91%
Divi's Laboratories Limited
equity
5.90%
Dr Reddys Laboratories Limited
equity
5.74%
Apollo Hospitals Enterprise Limited
equity
5.55%
Cipla Limited
equity
5.28%
Max Healthcare Institute Limited
equity
5.23%
Lupin Limited
equity
3.97%
Fortis Healthcare Limited
equity
3.43%
Laurus Labs Limited
equity
3.04%
Torrent Pharmaceuticals Limited
equity
3.03%
Aurobindo Pharma Limited
equity
2.76%
Glenmark Pharmaceuticals Limited
equity
2.56%
Alkem Laboratories Limited
equity
2.25%
Biocon Limited
equity
1.87%
Mankind Pharma Limited
equity
1.78%
Zydus Lifesciences Limited
equity
1.60%
IPCA Laboratories Limited
equity
1.52%
Aster DM Healthcare Limited
equity
1.32%
J B Chemicals and Pharma Ltd
equity
1.22%
Krishna Institute Of Medical Sciences Limited
equity
1.18%
Sai Life Sciences Limited
equity
1.03%
Gland Pharma Limited
equity
0.99%
Acutaas Chemicals Limited
equity
0.95%
Abbott India Limited
equity
0.92%
Neuland Laboratories Limited
equity
0.92%
Narayana Hrudayalaya Limited
equity
0.87%
Ajanta Pharma Limited
equity
0.85%
Wockhardt Limited
equity
0.82%
Dr. Lal Path Labs Limited
equity
0.75%
Granules India Limited
equity
0.73%